Saul Rivkin, MD, President
Richard Clarfeld MD, Principal Investigator, NSABP
Benjamin Greer, MD, Principal Investigator, GOG
Leona Holmberg, MD, Member, Executive Committee
Nancy Knudsen, RN Program Administrator
The mission of the Puget Sound Oncology Consortium (PSOC) is to:
PSOC Organization
The PSOC is governed by a board of directors according to its bylaws. PSOC officers are elected to three-year terms by PSOC members. The organization consists of individual physicians in private practice and academia, and representatives of hospitals and cancer care organizations in the greater Puget Sound area. PSOC has a membership of over 350 physicians, including 185 medical and radiation oncologists, throughout the state of Washington. Dr. Saul Rivkin has been the group's president since its inception.
Clinical Trials
Physicians in the community may enter patients on national or local protocols through the PSOC. Patients are treated by their primary physician. Participants in the STAR trial are seen at the Hutch or one of our 5 satellites. For national trials PSOC manages the administrative work, screens potential patients for eligibility, registers patients to the trials, assures protocol compliance, monitors toxicities and performs data collection and data submission. For local trials, in addition to the above, the PSOC staff assist with the development of the protocols and conducts data entry and analysis.
National Clinical Treatment Trials
PSOC participates in two national groups:
Cancer Prevention
The NSABP Study of Tamoxifen and Raloxifene (STAR) opened to enrollment in July 1999. STAR is designed to determine whether the osteoporosis prevention and treatment drug, raloxifene is as effective as tamoxifen in reducing breast cancer risk. In 1998, tamoxifen was shown to reduce the chance of developing invasive and noninvasive breast cancer by about half in the Breast Cancer Prevention Trial (BCPT), a study of over 13,000 premenopausal and postmenopausal women at increased risk for breast cancer. The FHCRC is one of 500 Centers participating in the STAR trial across the US, Puerto Rico and Canada. Dr. Clarfeld is the Principal Investigator, and Dr. Anne McTiernan is the Co-Principal Investigator. Joelle Machia, Coordinator at FHCRC, is a member of the National Coordinator Committee for this trial. We have 4 satellites participating: Bend Memorial Clinic in Bend Oregon, Olympic Hematology and Oncology in Bremerton, Rockwood Clinic in Spokane and St. Joseph's Cancer Center in Bellingham. We have accrued 170 patients to date.
Local PSOC Clinical Trials
The PSOC has four active committees - the breast committee, the gynecologic committee, the lung committee and the lymphoma committee - that develop and review protocols to conduct locally. Physicians throughout the Northwest participate in PSOC protocols. We also have 17 institutions in Washington, Idaho, Montana, Oregon, California and Hawaii participating in the high-dose therapy/stem cell transplant studies. The current PSOC protocols open to accrual include:
Education and Information Services
PSOC sponsors periodic meetings that include PSOC business and guest lecturers who provide scientific updates. The meetings have brought a series of distinguished lecturers to Seattle over the years. PSOC programs are certified for continuing medical education credit. The PSOC publishes a clinical trial priority list 4 times per year. This list includes clinical trials from SWOG, NSABP, GOG, PSOC and individual institutions. The list is arranged by disease site, and gives the study numbers, treatment regimen, and brief eligibility information.
PSOC has a web page for its members that provides quick information about the trials, consent forms and a list of our educational lectures.
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
